Aortic valve sclerosis is associated with preclinical cardiovascular disease in hypertensive adults: The Hypertension Genetic Epidemiology Network study

Journal of Hypertension

Volumn 23, Issue 4, 2005, Pages 867-873

  Agno, Felizen S ^a   Chinali, Marcello ^a   Bella, Jonathan N ^b   Liu, Jennifer E ^a   Arnett, Donna K ^c   Kitzman, Dalane W ^d   Oberman, Albert ^e   Hopkins, Paul N ^f   Rao, Dabeeru C ^g   Devereux, Richard B ^a,h  

^a WEILL CORNELL MEDICAL COLLEGE   (United States)

^b ALBERT EINSTEIN COLLEGE OF MEDICINE   (United States)

^c UNIVERSITY OF MINNESOTA   (United States)

^d WAKE FOREST SCHOOL OF MEDICINE   (United States)

^e UNIVERSITY OF ALABAMA AT BIRMINGHAM   (United States)

^f UNIVERSITY OF UTAH   (United States)

^g WASHINGTON UNIVERSITY   (United States)

^h WEILL CORNELL MEDICAL CENTER   (United States)

Author keywords

Aortic valve; Atherosclerosis; Echocardiography; Hypertension

Indexed keywords

CHOLESTEROL; FENFLURAMINE; HIGH DENSITY LIPOPROTEIN CHOLESTEROL;

ADULT; AGE; AGED; AORTA VALVE REGURGITATION; AORTIC VALVE SCLEROSIS; ARTICLE; ATHEROSCLEROSIS; CARDIOVASCULAR DISEASE; CHOLESTEROL BLOOD LEVEL; CONTROLLED STUDY; DIABETES MELLITUS; DISEASE ASSOCIATION; ECHOCARDIOGRAPHY; FEMALE; GENDER; HEART LEFT ATRIUM; HEART LEFT VENTRICLE FILLING; HIGH RISK POPULATION; HUMAN; HYPERCHOLESTEROLEMIA; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PREVALENCE; PRIORITY JOURNAL; PROGNOSIS; RACE; SMOKING; VALVULAR HEART DISEASE;

EID: 20244378548     PISSN: 02636352     EISSN: None     Source Type: Journal    
DOI: 10.1097/01.hjh.0000163157.14493.c7     Document Type: Article

References (51)

1. Otto CM. Valvular heart disease: prevalence and clinical outcomes. In: Otto CM, editor. Valvular heart disease, 2nd edition. Philadelphia: PA; W.B. Saunders; 2004, pp. 1-17.
2. Otto CM. Why is aortic sclerosis associated with adverse clinical outcome? J Am Coll Cardiol 2004; 43:176-178.
3. Branch KR, O'Brien KD, Otto CM. Aortic valve sclerosis as a marker of active atherosclerosis. Curr Cardiol Rep 2002; 4:111-117.
4. Stewart BF, Siscovick D, Lind BK, Gardin JM, Gottdiener JS, Smith VE, et al. Clinical factors associated with calcifié aortic valve disease. J Am Coll Cardiol 1997; 29:630-634.
5. Agmon Y, Khandheria BK, Meissner I, Sicks JD, O'Fallon WM, Wiebers DO, et al. Aortic valve sclerosis and aortic atherosclerosis: different manifestations of the same disease. J Am Coll Cardiol 2001; 38:827-834.
6. Boon A, Cheriex E, Lodder J, Kessels F. Cardiac valve calcification: characteristics of patients with calcification of the mitral annulus or aortic valve. Heart 1997; 78:472-474.
7. Lindroos M, Kupari M, Valvanne J, Strandberg T, Heikkila J, Tilvis R. Factors associated with calcific aortic valve degeneration in the elderly. Eur Heart J 1994; 15:865-870.
8. Aronow WS, Schwartz KS, Koenigsberg M. Correlation of serum lipids, calcium, and phosphorus, diabetes mellitus and history of systemic hypertension with presence or absence of calcified or thickened aortic cusps or root in elderly patients. Am J Cardiol 1987; 59:998-999.
9. Gotoh T, Kuroda T, Yamasawa M, Nishinaga M, Mitsuhashi T, Seino Y, et al. Correlation between lipoprotein(a) and aortic valve sclerosis assessed by echocardiography (the JMS Cardiac Echo and Cohort Study). Am J Cardiol 1995; 76:928- 932.
10. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Nieminen MS, et al. Aortic valve sclerosis, hemodynamics, and cardiovascular risk in hypertension: a LIFE substudy [Abstract]. J Am Coll Cardiol 2002; 39(suppl A):421A.
11. Otto CM, Lind BK, Kitzman DW, Gersh BJ, Siscovick DS. Association of aortic valve sclerosis with cardiovascular mortality and morbidity in the elderly. N Engl J Med 1999; 341:142-147.
12. Teerlink JR, Newman TB, Schiller NB, Foster E. Aortic sclerosis, as well as aortic stenosis, is a significant predictor of mortality [Abstract]. Circulation 1997, 96(suppl 1):1-82.
13. Aronow WS, Ahn C, Shirani J, Kronzon I. Comparison of frequency of new coronary events in older subjects with and without valvular aortic sclerosis. Am J Cardiol 1999; 83:599-600.
14. Olsen MH, Wachtell K, Bella JN, Palmieri V, Gerdts E, Nieminen MS, et al. Does aortic valve sclerosis predict cardiovascular events independent of albuminuria in hypertension? A LIFE Study [Abstract]. J Am Coll Cardiol 2003; 41(suppl A):510A.
15. Otto CM, Kuusisto J, Reichenbach DD, Gown AM, O'Brien KD. Characterization of the early lesion of 'degenerative' valvular aortic stenosis. Histological and immunohistochemical studies. Circulation 1994; 90:844-853.
16. O'Brien KD, Reichenbach DD, Marcovina SM, Kuusisto J, Alpers CE, Otto CM. Apolipoproteins B, (a), and E accumulate in the morphologically early lesion of 'degenerative' valvular aortic stenosis. Arterioscler Thromb Vasc Biol 1996; 16:523-532.
17. Carabello BA. Aortic sclerosis - a window to the coronary arteries? N Engl J Med 1999; 341:193-195.
18. Adler Y, Vaturi M, Herz I, lakobishvili Z, Toaf J, Fink N, et al. Nonobstructive aortic valve calcification: a window to significant coronary artery disease. Atherosclerosis 2002; 161:193-197.
19. Chandra HR, Goldstein JA, Choudhary N, O'Neill CS, George PB, Gangasani SR, et al. Adverse outcome in aortic sclerosis is associated with coronary artery disease and inflammation. J Am Coll Cardiol 2004; 43:169-175.
20. Galante A, Pietroiusti A, Vellini M, Piccolo P, Possati G, Bonis MD, et al. C-reactive protein is increased in patients with degenerative aortic valvular stenosis. J Am Coll Cardiol 2001; 38:1078-1082.
21. Poggianti E, Venneri L, Chubuchny V, Jambrik Z, Baroncini LA, Picano E. Aortic valve sclerosis is associated with systemic endothelial dysfunction. J Am Coll Cardiol 2003; 41:136-141.
22. Avakian SD, Annicchino-Bizzacchi JM, Grinberg M, Ramires JAF, Mansur AP. Apolipoproteins Al, B, and E polymorphisms in severe aortic valve stenosis. Clin Genet 2001; 60:381-384.
23. Ortlepp JR, Hoffmann R, Ohme F, Lauscher J, Bleckmann F, Hanrath P. The vitamin D receptor genotype predisposes to the development of calcific aortic valve stenosis. Heart 2001; 85: 635-638.
24. Williams RR, Rao DC, Ellison RC, Arnett DK, Heiss G, Oberman A, et al. NHLBI family blood pressure program: methodology and recruitment in the HyperGEN network. Hypertension Genetic Epidemiology Network. Ann Epidemiol 2000; 10:389-400.
25. al'Absi M, Devereux RB, Lewis CE, Kitzman DW, Rao DC, Hopkins PN, et al. Blood pressure responses to acute stress and left ventricular mass (The Hypertension Genetic Epidemiology Network Study). Am J Cardiol 2002; 89:536-540.
26. The Sixth Report of the Joint National Committee on Prevention Detection Evaluation and Treatment of High Blood Pressure. Arch Intern Med 1997; 157:2413-2446.
27. Lukaski HC, Johnson PE, Bolonchuk WW, Lykken GI. Assessment of fat-free mass using bioelectrical impedance measurements of the human body. Am J Clin Nutr 1985; 41:810-817.
28. Bella JN, Devereux RB, Roman MJ, O'Grady MJ, Welty TK, Lee ET, et al. Relations of left ventricular mass to fat-free and adipose body mass: the Strong Heart Study. Circulation 1998; 98:2538-2544.
29. American Diabetes Association. Report of the Expert Committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 1997; 20:1183-1197.
30. Devereux RB, de Simone G, Palmieri V, Oberman A, Hopkins PN, Kitzman DW, et al. Relation of insulin to left ventricular geometry and function in African American and white hypertensive adults: the HyperGEN study. Am J Hypertens 2002; 15:1029-1035.
31. Devereux RB, Roman MJ, de Simone G, O'Grady MJ, Paranicas M, Yeh JL, et al., for the Strong Heart Study Investigator. Relations of left ventricular mass to demographic and hemodynamic variables in American Indians: the Strong Heart Study. Circulation 1997; 96:1416-1423.
32. Devereux RB, Roman MJ, Paranicas M, O'Grady MJ, Wood EA, Howard BV, et al. Relations of Doppler stroke volume and RS components to left ventricular stroke volume in normotensive and hypertensive American Indians: the Strong Heart Study. Am J Hypertens 1997; 10:619-628.
33. Devereux RB, Roman MJ. Evaluation of cardiac and vascular structure by echocardiography and other noninvasive techniques. In: Laragh JH, Brenner BM (editors): Hypertension: pathophysiology, diagnosis, treatment, 2nd edition. New York: Raven Press; 1995, pp. 1969-1985.
34. Sahn DJ, DeMaria A, Kisslo J, Weyman A. The Committee on M-mode Standardization of the American Society of Echocardiography: recommendations regarding quantitation in M-mode echocardiography. Results of a survey of echocardiographic measurements. Circulation 1978; 58:1072-1083.
35. Schiller NB, Shah PM, Crawford M, DeMaria A, Devereux R, Feigenbaum H, et al. American Society of Echocardiography Committee on Standards, Subcommittee on Quantitation of Two-Dimensional Echocardiograms: recommendations for quantitation of the left ventricle by two-dimensional echocardiography. J Am Soc Echocardiogr 1989; 2:358-367.
36. Palmieri V, Dahlöf B, DeQuattro V, Sharpe N, Bella JN, de Simone G, et al. Reliability of echocardiographic assessment of left ventricular structure and function: the PRESERVE Study. J Am Coll Cardiol 1999; 34:1625-1632.
37. Olsen MH, Wachtell K, Bella JB, Liu JE, Boman K, Gerdts E, et al. Effect of Losartan versus Atenolol on aortic valve sclerosis (a LIFE Substudy). Am J Cardiol 2004; 94:1076-1080.
38. Devereux RB, Alonso DR, Lutas EM, Gottlieb GJ, Campo E, Sachs I, et al. Echocardiographic assessment of left ventricular hypertrophy: comparison to necropsy findings. Am J Cardiol 1986; 57:450-458.
39. Koren MJ, Devereux RB, Casale PN, Savage DD, Laragh JH. Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med 1991; 114:345-352.
40. Liu JE, Roman MJ, Pini R, Schwartz JE, Pickering TG, Devereux RB. Cardiac and arterial target organ damage in adults with elevated ambulatory and normal office blood pressure. Ann Intern Med 1999; 131:564-572.
41. Teichholz LE, Kreulen T, Herman MV, Gorlin R. Problems in echocardiographic volume determinations: echocardiographic-angiographic correlations in the presence or absence of asynergy. Am J Cardiol 1976; 37:7-11.
42. de Simone G, Devereux RB, Roman MJ, Ganau A, Saba PS, Alderman MH, et al. Assessment of left ventricular function by the mid-wall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol 1994; 23:1444-1451.
43. Gaasch WH, Zile MR, Hoshino PK, Apstein CS, Blaustein AS. Stress-shortening relations and myocardial blood flow in compensated and failing canine hearts with pressure-overload hypertrophy. Circulation 1989; 79:872-873.
44. Devereux RB, de Simone G, Pickering TG, Schwartz JE, Roman MJ. Relation of left ventricular midwall function to cardiovascular risk factors and arterial structure and function. Hypertension 1998; 31:929-936.
45. Casale PN, Devereux RB, Milner M, Zullo G, Harshfield GA, Pickering TG, et al. Value of echocardiographic measurement of mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med 1986; 105:173-178.
46. Ghali JK, Liao Y, Simmons B, Castaner A, Cao G, Cooper RS. The prognostic role of left ventricular hypertrophy in patients with or without coronary artery disease. Ann Intern Med 1992; 117:831-836.
47. Aurigemma GP, Gottdiener JS, Shemanski L, Gardin J, Kitzman DW. Predictive value of systolic and diastolic function for incident congestive heart failure in the elderly: the Cardiovascular Health Study. J Am Coll Cardiol 2001; 37:1042-1048.
48. Gandhi SK, Powers JC, Nomeir AM, Fowle K, Kitzman DW, Rankin KM, Little WC. The pathogenesis of acute pulmonary edema associated with hypertension. N Engl J Med 2001; 344:17-22.
49. Verdecchia P, Reboldi GP, Gattobigio R, Bentivoglio M, Borgioni C, Angeli F, et al. Atrial fibrillation in hypertension: predictors and outcome. Hypertension 2003; 41:218-223.
50. Hart RG, Halperin JL, Pearce LA, Anderson DC, Kronmal RA, McBride R, et al., for the Stroke Prevention in Atrial Fibrillation Investigators. Lessons from the stroke prevention in atrial fibrillation trials. Ann Intern Med 2003; 138:831-838.
51. Roberts WC. Morphologic features of the normal and abnormal mitral valve. Am J Cardiol 1983; 51:1005-1028.